Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis

BACKGROUND: Triple negative breast cancer (TNBC) is a highly heterogeneous and aggressive disease, and although no effective targeted therapies are available to date, about one-third of patients with TNBC achieve pathologic complete response (pCR) from standard-of-care anthracycline/taxane (ACT) che...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS Med
Main Authors: Jiang, Tingting, Shi, Weiwei, Wali, Vikram B., Pongor, Lőrinc S., Li, Charles, Lau, Rosanna, Győrffy, Balázs, Lifton, Richard P., Symmans, William F., Pusztai, Lajos, Hatzis, Christos
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2016
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5154510/
https://ncbi.nlm.nih.gov/pubmed/27959926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1002193
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki